Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection-Reference-Cited by-同舟云学术

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

Published:2011-11-28 Issue:18 Volume:25 Page:2269-2278
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Haubrich Richard H.,Riddler Sharon A.,Ribaudo Heather,DiRenzo Gregory,Klingman Karin L.,Garren Kevin W.,Butcher David L.,Rooney James F.,Havlir Diane V.,Mellors John W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference25 articles.

1. Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior.;Wu;J Infect Dis,2004

2. Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy.;Polis;Lancet,2001

3. Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models.;Ding;Biostatistics,2001

4. Pharmacodynamic effects of zidovudine 600mg onceday versus 300mg twiceday in therapy-naive patients infected with human immunodeficiency virus.;Ruane;Pharmacotherapy,2004

5. Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals.;Louie;AIDS,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers;Clinical Infectious Diseases;2019-05-25

2. Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice;Virus Genes;2019-02-22

3. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART;Journal of Antimicrobial Chemotherapy;2018-09-20

4. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies;The Journal of Infectious Diseases;2018-08-06

5. Virologic outcomes in early antiretroviral treatment: HPTN 052;HIV Clinical Trials;2017-04-07